A pan-European eldercare leader turning a debt overhang into an equity re-rating—if occupancy, tariffs, and staffing hold the line.
Overview
Clariane SE (formerly Korian) is a pan-European integrated care leader serving elderly and vulnerable populations through a continuum spanning Long-Term Care nursing homes, Specialty Care rehabilitation/psychiatry clinics, and Community Care living/home-care services. The investment backdrop is structurally favorable: the European “Silver Economy” is accelerating, with the 80+ cohort projected to grow ~3.1% annually and the 75+ population expected to rise ~40% by 2040, underpinning persistent demand for medicalized capacity. Clariane operates at scale (1,213 facilities; ~90,000 beds) across six key geographies, with 2025 revenue of ~€5.31bn and resilient ~4.5% organic growth despite major restructuring and disposals. Its differentiation relies on a quality-led model (Positive Care methodology, ~99% ISO-9001 certification, strong audit ratings) and clinical specialization that improves referral credibility and pathway capture. After completing a substantial deleveraging program, the company is transitioning from “survival mode” to an operational recovery focused on occupancy normalization, outpatient specialty expansion, and asset-light growth—while still carrying a high leverage overhang that will govern valuation until materially reduced.